Watch Ticker

Synlogic, Inc. Common Stock

Go to Synlogic, Inc. Common Stock Website

$1.44

0.04 (2.86%)

Live

Previous Close

$1.4

Day Range

$1.392 - $1.44

Previous Day Range

$1.37 - $1.5

Market Cap

$17.5 million USD

Day Vol.

7219

Previous Day Vol.

84198

Currency

USD

Primary Exchange

Nasdaq

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Usin...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Synlogic, Inc. - Synlogic Reports First Quarter 2024 Financial Results

CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the first quarter 2024 and provided a corporate update.

Related tickers: SYBX.

Read Full Article

Zacks Equity Research - Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of -54.05% and 2.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: SYBX, BRNS.

Read Full Article

Trending Tickers

Please sign in to view